Efficacy and safety of pop-titrated versus fixed-energy trans-scleral diode laser cyclophotocoagulation for refractory glaucoma.
Marcelo O Stevenson-FernandezAlejandro Rodríguez-GarciaAngelina Espino-Barros PalauPedro Mario Gonzalez-MadrigalPublished in: International ophthalmology (2018)
Pop-titrated DLTSC represents an effective and safe option for the management of refractory glaucoma. We found no statistically significant difference in success rates among both groups. However, there was a significantly higher risk of hypotony in eyes treated with the fixed-energy protocol.